Association of Genetic Variants in the Adiponectin Gene with Metabolic Syndrome: A Case-Control Study and a Systematic Meta-Analysis in the Chinese Population

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gao, Meng ^a   Ding, Daxia ^a   Huang, Jinghua ^a   Qu, Yali ^b   Wang, Yu ^c   Huang, Qingyang ^a  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b Wuhan Medical Emergency Center   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTIDINE; GUANIDINE; THYMIDINE;

ADIPOQ GENE; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875937571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058412     Document Type: Article

References (89)

1. Eckel RH, Grundy SM, Zimmet PZ, (2005) The metabolic syndrome. Lancet 365: 1415-28.
2. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, et al. (2007) Development of diabetes in Chinese with the metabolic syndrome, a 6-year prospective study. Diabetes care 30(6): 1430-1436.
3. Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, et al (2007) Metabolic syndrome increases all-cause and vascular mortality, The Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (oxf) 66(5): 666-671.
4. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285: 2486-2497.
5. Alberti KG, Zimmet P, (2005) IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366 (9491): 1059-1062.
6. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 15: 539-553.
7. Expert Panel on Metabolic Syndrome of Chinese Diabetes Society (2004) Recommendations on metabolic syndrome of Chinese diabetes society (Chinese). Chin J Diab12: 156-161.
8. Zhuo Q, Wang ZQ, Fu P, Piao JH, Tian Y, et al. (2010) Association between adiponectin and metabolic syndrome in older adults from major cities of China. Biomed Environ Sci 23(1): 53-61.
9. Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, et al. (2010) Prevalence of the metabolic syndrome in Pudong new area of Shanghai using three proposed definitions among Chinese adults. BMC Public Health 10: 246.
10. Ford ES, Giles WH, Dietz WH, (2002) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287: 356-359.
11. Lorenzo C, Williams K, Hunt KJ, Haffner SM, (2007) The national cholesterol dducation program - adult treatment panel III, international diabetes federation, and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30: 8-13.
12. Bosy-Westphal A, Onur S, Geisler C, Wolf A, Korth O, (2007) Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J Obes (Lond) 31(5): 784-90.
13. Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, et al. (2008) Prevalence and heritability of the metabolic obesity reviews genetics of metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 45(9): 572-77.
14. Bellia A, Giardina E, Lauro D, Tesauro M, Di Fede G, et al. (2009) "The Linosa Study": epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. Nutr Metab Cardiovasc Dis 19(7): 455-61.
15. Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, et al. (2005) Heritabilities of the metabolic syndrome and its components in the northern manhattan family study. Diabetologia 48(10): 2006-2012.
16. Zhang S, Liu X, Yu Y, Hong X, Christoffel KK, et al. (2009) Genetic and environmental contributions to phenotypic components of metabolic syndrome: a population-based twin study. Obesity (SilverSpring) 17(8): 1581-7.
17. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, et al. (2000) Quantitative trait loci on chromosomes 3 and influence phynotype of the metabolic syndrome. Proc Natl Acad Sci USA 97(26): 14478-83.
18. Ng MC, So WY, Lam VK, Cockram CS, Bell GI, et al. (2004) Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 53(10): 2676-83.
19. Langefeld CD, Wagenknecht LE, Rotter JI, Williams AH, Hokanson JE, et al. (2004) Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 53(4): 1170-4.
20. Edwards KL, Wan JY, Hutter CM, Fong PY, Santorico SA, (2011) Multivariate linkage scan for metabolic syndrome traits in families with type 2 diabetes. Obesity (Silver Spring) 19(6): 1235-43.
21. Farook VS, Puppala S, Schneider J, Fowler SP, Chittoor G, et al. (2012) Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican Americans. Obesity (Silver Spring) 20(10): 2083-92.
22. Arya R, Duggirala R, Almasy L, Rainwater DL, Mahaney MC, et al. (2002) Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat Genet 30(1): 102-5.
23. Loos RJ, Katzmarzyk PT, Rao DC, Rice T, Leon AS, et al. (2003) Genome-wide linkage scan for the metabolic Syndrome in the HERITAGE Family Study. J Clin Endocrinol Metab 88(12): 5935-43.
24. Tang W, Miller MB, Rich SS, North KE, Pankow JS, et al. (2003) Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 52(11): 2840-2847.
25. Stein CM, Song Y, Elston RC, Jun G, Tiwari HK, et al. (2003) Structural equation model-based genome scan for the metabolic syndrome. BMC Genet 4Suppl 1: S99.
26. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, et al. (2005) Quantitative trait loci for metabolic syndrome in the Hypertension Genetic Epidemiology Network study. Obes Res 13(11): 1885-90.
27. Bosse Y, Despres JP, Chagnon YC, Rice T, Rao DC, et al. (2007) Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis. Obesity (Silver Spring) 15(3): 544-50.
28. Edwards KL, Hutter CM, Wan JY, Kim H, Monks SA, (2008) Genome-wide linkage scan for the metabolic syndrome: The GENNID Study. Obesity (Silver Spring) 16(7): 1596-1601.
29. Cheng CY, Lee KE, Duggal P, Moore EL, Wilson AF, et al. (2010) Genome-wide linkage analysis of multiple metabolic factors: evidence of genetic heterogeneity. Obesity (Silver Spring) 18(1): 146-52.
30. Tam CH, Lam VK, So WY, Ma RC, Chan JC, et al. (2010) Genome-wide linkage scan for factors of metabolic syndome in a Chinese population. BMC Genetics 11: 14.
31. Zabaneh D, Balding DJ, (2010) A genome-wide association study of the metabolic syndrome in Indian Asian men. Plos One 5(8): e11961.
32. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, et al. (2011) A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60(4): 1329-39.
33. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, et al. (2012) Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 5(2): 242-9.
34. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, et al. (2002) Plasma adiponectin levels in overweight and obese Asians. Obes Res. 10(11): 1104-10.
35. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X, (2008) Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 16(1): 172-8.
36. Ryu HK, Yu SY, Park JS, Choi YJ, Huh KB, et al. (2010) Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients. J Am Coll Nutr 29(3): 171-8.
37. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I, (2010) Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb 17(12): 1201-11.
38. Koh SB, Yoon J, Kim JY, Yoo BS, Lee SH, et al. (2011) Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study. Yonsei Med J52 (2): 234-41.
39. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6): 1595-99.
40. Kovac IP, Havlik RJ, Foley D, Peila R, Hernandez D, et al. (2007) Linkage and association analyses of type 2 diabetes/impaired glucose metabolism and adiponectin serum levels in Japanese Americans from Hawaii. Diabetes 56(2): 537-40.
41. Lee CY, Lee CH, Tsai S, Huang CT, Wu MT, et al. (2009) Association between serum leptin and adiponectin levels with risk of insulin resistance and impaired glucose tolerance in non-diabetic women. Kaohsiung J Med Sci 25(3): 116-25.
42. Li S, Shin HJ, Ding EL, van Dam RM, (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302(2): 179-88.
43. Li Y, Yatsuya H, Iso H, Toyoshima H, Tamakoshi K, (2012) Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up. Diabetes Metab Res Rev 28(4): 349-56.
44. Matsubara M, Maruoka S, Katayose S, (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87(6): 2764-2769.
45. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G, (2002) Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25(6): 971-976.
46. Huang KC, Chen CL, Chuang LM, Ho SR, Tai TY, et al. (2003) Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 88(9): 4130-34.
47. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, et al. (2003) Decreased plasma adiponectin concentration in patients with essential hypertension. Hypertension 16(1): 72-75.
48. Shankar A, Marshall S, Li J, (2008) The association between plasma adiponectin level and hypertension. Acta Cardiol 63(2): 160-5.
49. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86(8): 3815-19.
50. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360(9326): 57-58.
51. Haluzik M, Parizkova J, Haluzik MM, (2004) Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53(2): 123-9.
52. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50(9): 2094-99.
53. Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, et al. (2002) Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25(2): 376-80.
54. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, et al. (2004) Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 110(24): 3687-92.
55. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, et al. (2003) Blockade of the renin - angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42(1): 76-81.
56. Liu DX, Hua Qi, Guo JC, Liu RK, Yang Z, et al. (2006) Difference of adiponectin gene exon 2 Glyl5Gly genotype and allele frequency between patients with metabolic syndrome and normal persons. Chin J Clin Rehabilitation 10(6): 4-6.
57. Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, et al. (2007) Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 86(2): 509-13.
58. Huang FZ (2008) The association of adiponectin gene SNP+45, SNP+276 with metabolic syndrome and plasma adiponectin concentration. Chinese Master's Dissertations Full-Text Database.
59. Li YP, Zhang Y, Li XL, Deng DY, Yang M, et al. (2009) The association of adiponectin gene SNP+45, SNP+276 and SNP-11377 with metabolic syndrome. Clin Focus 24(9): 786-788.
60. Cai Q, Liu HJ, Chen T, Zhu MC, (2010) Mononucleotide polymorphism at +45 and +276 site of adiponectin gene in aircrew with metabolic syndrome. Clin J Med Officers 38(5): 813-815.
61. Zhu XW, Wu WJ, Bu RF, Deng ZX, Hua JL, et al. (2010) Studies on adiponectin gene polymorphisms in patients with metabolic syndrome. Shandong Med J 50(29): 10-12.
62. Yao M (2004) The relationship between adiponectin gene and metabolic syndrome. Chinese Doctor's Dissertations Full-Text Database.
63. Li YP, Yang M, Xiong YX, Li XL, Xu B, et al. (2010) Adiponectin gene SNP-11377 and SNP-4522 haplotypes are related to metabolic syndrome. Basic Clin Med 30(12): 1288-92.
64. Bu RF, Wu WJ, Hua JL, Shen H, Xu L, et al. (2011) The association of adiponectin gene polymorphism and serum adiponectin level with metabolic syndrome in older. Chin J Gerontology 31: 4112-14.
65. Leu HB, Chung CM, Lin SJ, Jong YS, Pan WH, et al. (2011) Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. Plos One 6(5): e19999.
66. Du J, Ye Xh, Li Q, Yu X, Cheng J, et al. (2012) Genetic variants in the ADIPOQ gene and the risk of metabolic syndrome: a case-control study of a Chinese Han population. Ann Hum Genet 76(2): 101-9.
67. Chen F, Wu HL, Yang QL, Liu YJ, Wang J, et al. (2012) Study on the correlation of adiponectin gene polymorphism and coronary heart disease in the patients with metabolic syndrome in Han nationlity population in Ningxia. Clin J Crit Care Med 32(1): 24-29.
68. Wang SJ, Jia WP, Bao YQ, Lu JQ, (2012) Association of adiponectin gene polymorphism with metabolic syndrome. J Chinese Practical Diagnosis and Therapy 26(7): 659-61.
69. Li XT, Wei DY, He H, Zhang J, Wang C, et al. (2012) Association of the adiponectin gene (ADIPOQ) +45 T > G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China. Asia Pac J Clin Nutr 21 (2): 296-301.
70. Hung J, Mc Quillan BM, Thompson PL, Beilby JP, (2008) Circulating adiponectin levels associate with inammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond) 32(5): 772-779.
71. King GA, Deemer SE, Thompson DL (2012) Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol (Suppl 1): 41-9.
72. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, et al. (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86(9): 4321-25.
73. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, et al. (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted diponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11(21): 2607-14.
74. Menzaghi C, Trischitta V, Doria A, (2007) Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56(5): 1198-1209.
75. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, et al. (2008) Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 57(12): 3353-59.
76. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, et al. (2008) Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 17(4): 737-44.
77. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, et al. (2010) Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European 32 individuals. Atherosclerosis 208(2): 412-20.
78. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, et al. (2012) Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 8(3): e1002607.
79. González-Sánchez JL, Zabena CA, Martínez-Larrad MT, Fernández-Pérez C, Pérez-Barba M, et al. (2005) An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13(5): 807-12.
80. Li S, Li L, Li K, Qi X, Hoekema D, et al. (2008) Association of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case-control studies. Clin Endocrinol (Oxf) 68(6): 885-9.
81. Gong M, Long J, Liu Q, Deng HC, (2010) Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 325(1-2): 78-83.
82. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, et al. (2011) Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54(9): 2303-14.
83. Li Y, Li X, Shi L, Yang M, Yang Y, et al. (2011) Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS One 6(5): e19686.
84. Chen J, Han XY, Ji LN, (2012) Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. Endocrine 42(2): 307-20.
85. Zhao T, Zhao J, (2011) Genetic effects of adiponectin on blood lipids and blood pressure. Clin Endocrinol(Oxf) 74(2): 214-222.
86. Xi B, He D, Wang Q, Xue J, Liu M, et al. (2012) Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese. Mol Biol Rep 39(9): 8771-5.
87. Yu Z, Han S, Cao X, Zhu C, Wang X, et al. (2012) Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) 20(2): 396-406.
88. Liu DM, Jin LZ, Yu DM, Li G, Zhang J, et al. (2004) Research of T2DM and adiponectin gene polymorphism. Chin J Diabetes 12(6): 397-8.
89. Liu F, He ZY, Deng S, Zhang H, Li N, et al. (2011) Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. Mol Biol Rep 38(3): 1983-88.